Serum Cytokine Profile, Beta-Hexosaminidase A Enzymatic Activity and GM2 Ganglioside Levels in the Plasma of a Tay-Sachs Disease Patient after Cord Blood Cell Transplantation and Curcumin Administration: A Case Report
Authors:
- Alisa A. ShaimardanovaASAlisa A. Shaimardanova
- Daria S. ChulpanovaDCDaria S. Chulpanova
- Valeriya V. SolovyevaVSValeriya V. Solovyeva
- Ekaterina E. GaraninaEGEkaterina E. Garanina
- Ilnur I. SalafutdinovISIlnur I. Salafutdinov
- Alexander Vladimirovich LaikovALAlexander Vladimirovich Laikov
- Vadim V. KursenkoVKVadim V. Kursenko
- Lisa ChakrabartiLCLisa Chakrabarti
- Ekaterina Yu. ZakharovaEZEkaterina Yu. Zakharova
- Tatiana M. BukinaTBTatiana M. Bukina
- Galina V. BaydakovaGBGalina V. Baydakova
- Albert Anatolyevich RizvanovAlbert Anatolyevich Rizvanov
Open Access
Abstract
Tay-Sachs disease (TSD) is a progressive neurodegenerative disorder that occurs due to a deficiency of a β hexosaminidase A (HexA) enzyme, resulting in the accumulation of GM2 gangliosides. In this work, we analyzed the effect of umbilical cord blood cell transplantation (UCBCT) and curcumin administration on the course of the disease in a patient with adult TSD. The patient’s serum cytokine profile was determined using multiplex analysis. The level of GM2 gangliosides in plasma was determined using mass spectrometry. The enzymatic activity of HexA in the plasma of the patient was assessed using a fluorescent substrate assay. The HexA α-subunit (HexA) concentration was determined using ELISA. It was shown that both UCBCT and curcumin administration led to a change in the patient’s cytokine profile. The UCBCT resulted in an increase in the concentration of HexA in the patient’s serum and in an improvement in the patient’s neurological status. However, neither UCBCT nor curcumin were able to alter HexA activity and the level of GM2 in patient’s plasma. The data obtained indicate that UCBCT and curcumin administration can alter the immunity of a patient with TSD, reduce the level of inflammatory cytokines and thereby improve the patient’s condition.Keywords
Funding Information
- Ministry of Science and Higher Education of the Russian Federation (#0671-2020-0058)
This publication has 83 references indexed in Scilit:
- Diverse effects of a low dose supplement of lipidated curcumin in healthy middle aged peopleNutrition Journal, 2012
- The ageing systemic milieu negatively regulates neurogenesis and cognitive functionNature, 2011
- The Effect of Epidermal Growth Factor in the Injured Brain after Trauma in RatsJournal of Neurotrauma, 2010
- Characterization of Gaucher disease bone marrow mesenchymal stromal cells reveals an altered inflammatory secretomeBlood, 2009
- Unilaterally and rapidly progressing white matter lesion and elevated cytokines in a patient with Tay–Sachs diseaseBrain and Development, 2009
- Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseasesThe International Journal of Biochemistry & Cell Biology, 2009
- Umbilical cord blood transplantation for juvenile metachromatic leukodystrophyAnnals of Neurology, 2008
- Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomesBlood, 2008
- Pharmacokinetics of Curcumin Conjugate Metabolites in Healthy Human SubjectsCancer Epidemiology, Biomarkers & Prevention, 2008
- Cytokine profiles of cord and adult blood leukocytes: differences in expression are due to differences in expression and activation of transcription factorsBMC Immunology, 2007